Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term EXPRESSION. Found 62 abstracts

no pagination
Burger RA, Brady MF, Bookman MA, Monk BJ, Walker JL, Homesley HD, Fowler J, Greer BE, Boente M, Fleming GF, Lim PC, Rubin SC, Katsumata N, Liang SX. Risk Factors for GI Adverse Events in a Phase III Randomized Trial of Bevacizumab in First-Line Therapy of Advanced Ovarian Cancer: A Gynecologic Oncology Group Study. Journal of Clinical Oncology. 2014 Apr;32(12):1210-7.   PMCID: PMC3986384
Gustafson HL, Yao S, Goldman BH, Lee K, Spier CM, LeBlanc ML, Rimsza LM, Cerhan JR, Habermann TM, Link BK, Maurer MJ, Slager SL, Persky DO, Miller TP, Fisher RI, Ambrosone CB, Briehl MM. Genetic polymorphisms in oxidative stress-related genes are associated with outcomes following treatment for aggressive B-cell non-Hodgkin lymphoma. American journal of hematology. 2014 Jun;89(6):639-45.   PMCID: 4137041
Purrington KS, Slager S, Eccles D, Yannoukakos D, Fasching PA, Miron P, Carpenter J, Chang-Claude J, Martin NG, Montgomery GW, Kristensen V, Anton-Culver H, Goodfellow P, Tapper WJ, Rafiq S, Gerty SM, Durcan L, Konstantopoulou I, Fostira F, Vratimos A, Apostolou P, Konstanta I, Kotoula V, Lakis S, Dimopoulos MA, Skarlos D, Pectasides D, Fountzilas G, Beckmann MW, Hein A, Ruebner M, Ekici AB, Hartmann A, Schulz-Wendtland R, Renner SP, Janni W, Rack B, Scholz C, Neugebauer J, Andergassen U, Lux MP, Haeberle L, Clarke C, Pathmanathan N, Rudolph A, Flesch-Janys D, Nickels S, Olson JE, Ingle JN, Olswold C, Slettedahl S, Eckel-Passow JE, Anderson SK, Visscher DW, Cafourek VL, Sicotte H, Prodduturi N, Weiderpass E, Bernstein L, Ziogas A, Ivanovich J, Giles GG, Baglietto L, Southey M, Kosma VM, Fischer HP, Reed MW, Cross SS, Deming-Halverson S, Shrubsole M, Cai QY, Shu XO, Daly M, Weaver J, Ross E, Klemp J, Sharma P, Torres D, Rudiger T, Wolfing H, Ulmer HU, Forsti A, Khoury T, Kumar S, Pilarski R, Shapiro CL, Greco D, Heikkila P, Aittomaki K, Blomqvist C, Irwanto A, Liu JJ, Pankratz VS, Wang XS, Severi G, Mannermaa A, Easton D, Hall P, Brauch H, Cox A, Zheng W, Godwin AK, Hamann U, Ambrosone C, Toland AE, Nevanlinna H, Vachon CM, Fergus J, Genica Network. Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer. Carcinogenesis. 2014 May;35(5):1012-9.   PMCID: PMC4004200
Ivanov SV, Miller J, Lucito R, Tang CL, Ivanova AV, Pei JM, Carbone M, Cruz C, Beck A, Webb C, Nonaka D, Testa JR, Pass HI. Genomic events associated with progression of pleural malignant mesothelioma. International journal of cancer. 2009 Feb;124(3):589-99.   PMCID: PMC2933144
Jenkins S, Raghuraman N, Eltoum I, Carpenter M, Russo J, Lamartiniere CA. Oral Exposure to Bisphenol A Increases Dimethylbenzanthracene-Induced Mammary Cancer in Rats. Environmental Health Perspectives. 2009 Jun;117(6):910-5.   PMCID: PMC2702405
Karp DD, Paz-Ares LG, Novello S, Haluska P, Garland L, Cardenal F, Blakely LJ, Eisenberg PD, Langer CJ, Blumenschein G, Johnson FM, Green S, Gualberto A. Phase II Study of the Anti-Insulin-Like Growth Factor Type 1 Receptor Antibody CP-751,871 in Combination With Paclitaxel and Carboplatin in Previously Untreated, Locally Advanced, or Metastatic Non-Small-Cell Lung Cancer. Journal of Clinical Oncology. 2009 May;27(15):2516-22.   PMCID: not NIH funded
Kashyap MK, Marimuthu A, Kishore CJ, Peri S, Keerthikumar S, Prasad TS, Mahmood R, Rao S, Ranganathan P, Sanjeeviah RC, Vijayakumar M, Kumar KV, Montgomery E, Kumar RV, Pandey A. Genomewide mRNA profiling of esophageal squamous cell carcinoma for identification of cancer biomarkers. Cancer Biology & Therapy. 2009 Jan;8(1):36-46.   PMCID: not NIH funded
McSorley MA, Alberg AJ, Allen DS, Allen NE, Brinton LA, Dorgan JF, Kaaks R, Rinaldi S, Helzlsouer KJ. Prediagnostic circulating follicle stimulating hormone concentrations and ovarian cancer risk. International journal of cancer. 2009 Aug;125(3):674-9.   PMCID: PMC2706295
Mehta MP, Shapiro WR, Phan SC, Gervais R, Carrie C, Chabot P, Patchell RA, Glantz MJ, Recht L, Langer C, Sur RK, Roa WH, Mahe MA, Fortin A, Nieder C, Meyers CA, Smith JA, Miller RA, Renschler MF. Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs timeto neurologic progression in non-small-cell lung cancer patients with brain metases: results of a phase III trial. International Journal of Radiation Oncology Biology Physics. 2009 Mar;73(4):1069-76.   PMCID: not NIH funded
Melnikov A, Scholtens D, Godwin A, Levenson V. Differential Methylation Profile of Ovarian Cancer in Tissues and Plasma. Journal of Molecular Diagnostics. 2009 Jan;11(1):60-5.   PMCID: PMC2607567
Xu M, Sharma A, Wiest DL, Sen JM. Pre-TCR-Induced beta-Catenin Facilitates Traversal through beta-Selection. Journal of Immunology. 2009 Jan;182(2):751-8.   PMCID: PMC 2657338
Yang DH, Smith ER, Cai KQ, Xu XX. c-fos Elimination Compensates for disabled-2 Requirement in Mouse Extraembryonic Endoderm. Development. Developmental Dynamics. 2009 Mar;238(3):514-23.   PMCID: PMC 2743073
Zhang M, Ho A, Hammond EH, Suzuki Y, Bermudez RS, Lee RJ, Pilepich M, Shipley WU, Sandler H, Khor LY, Pollack A, Chakravarti A. Prognostic value of surviving in locally advanced prostate cancer: study based on RTOG 8610. International Journal of Radiation Oncology Biology Physics. 2009 Mar;73(4):1033-42.   PMCID: PMC 2678565
Zhou Y, Hopper-Borge E, Shen T, Huang XC, Shi Z, Kuang YH, Furukawa T, Akiyama S, Peng XX, Ashby CR, Chen X, Kruh GD, Chen ZS. Cepharanthine is a potent reversal agent for MRP7(ABCC10)-mediated multidrug resistance. Biochemical pharmacology. 2009 Mar;77(6):993-1001.   PMCID: NIHMS 84766
Carbone M, Pannuti A, Zhang L, Testa JR, Bocchetta M. A Novel Mechanism of Late Gene Silencing Drives SV40 Transformation of Human Mesothelial Cells. Cancer Research. 2008 Nov;68(22):9488-96.
Chang JH, Cruo JT, Jiang D, Guo HT, Taylor JM, Block TM. Liver-specific MicroRNA miR-122 enhances the replication of hepatitis C virus in nonhepatic cells. Journal of Virology. 2008 Aug;82(16):8215-23.
Cohen EE, Rosen LS, Vokes EE, Kies MS, Forastiere AA, Worden FP, Kane MA, Sherman E, Kim S, Bycott P, Tortorici M, Shalinsky DR, Liau KF, Cohen RB. Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: Results from a phase II study. Journal of Clinical Oncology. 2008 Oct;26(29):4708-13.
Cvetkovic D, Williams SJ. Are there precursor lesions for ovarian cancer: A review. Srpski Arhiv Za Celokupno Lekarstvo. 2008 Mar;136:48-53.
Du J, Jablonski S, Yen TJ, Hannon GJ. Astrin regulates Aurora-A localization. Biochemical and Biophysical Research Communications. 2008 May;370(2):213-9.
Fakhry C, Westra WH, Cmelak SL, Ridge JA, Pinto H, Forastiere A, Gillison ML. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. Journal of the National Cancer Institute. 2008 Feb;100(4):261-9.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term EXPRESSION

EXPRESSION CARCINOMA GENE PROTEIN SURVIVAL MICE Oncology INHIBITION CELLS BREAST LUNG-CANCER TUMORS BREAST-CANCER IN-VIVO SUBGENOMIC REPLICONS BEVACIZUMAB INFECTION THERAPY BORDERLINE TUMORS Neurocognitive function MALIGNANT MESOTHELIOMA FSH c-Fos Disabled-2 (Dab2)-primitive endoderm-cell surface positioning-cell positioning TBX3 Brain metastases GENE-EXPRESSION PROFILE GENE-EXPRESSION CARCINOMAS LEUKEMIA MYOSIN-VI SURVIVIN Non-small-cell lung cancer RECEPTOR COACTIVATOR AIB1 microarrays Whole brain radiotherapy K562 CELLS PERFORATION MICROARRAY ANALYSIS REPRODUCTIVE HORMONES ESTROGEN-RECEPTOR PHASE-II ACTIVATION RESISTANCE GENES MRP ENTITY TEXAPHYRIN T-CELL-RECEPTOR MODULATION expression profiling SERINE-PROTEASE CENTROSOME INTEGRITY Survivin MATRIX METALLOPROTEINASE-2 CANCER-CELLS papillomatosis MITOTIC-SPINDLE CELL-LINES TRANSCRIPTION TRIAL CHEMOTHERAPY-NAIVE PATIENTS CHEMOTHERAPY FAMILY-HISTORY N-CADHERIN IGF HUMAN-CHROMOSOME 3P213 biomarkers Prostate cancer GASTRIC-CANCER tumor suppressors BRCA1 MESSENGER-RNA ANTI-APOPTOSIS GENE CA125 TAMOXIFEN RESISTANCE CANCERS WNT SIGNALING PATHWAY Aurora-A astrin ADAPTER PROTEIN ESTROGEN inclusion cysts HUMAN TUMORS GLYCOGEN-SYNTHASE KINASE-3 FENRETINIDE INTERFERON CELL-PROLIFERATION GASTRIC CARCINOMAS DIFFERENTIAL PROMOTER ULTRASOUND HEPATOCELLULAR-CARCINOMA END-POINTS SURFACE EPITHELIAL-CELLS Prognostic factor GROWTH bisphenol A apoptosis-mammary cancer-proliferation-steroid receptor coactivators LUTEINIZING-HORMONE HOMOZYGOUS DELETION REGION BOWEL TRANSCRIPTIONAL ACTIVATION DOUBLE-STRANDED-RNA GLAND DEVELOPMENT PERINATAL EXPOSURE RANDOMIZED-TRIAL epithelial polarity organization-MAPK-mouse embryos ONCOSTATIN-M POSTMENOPAUSAL WOMEN ROMA DEVELOPING DROSOPHILA EYE TUMOR copy number alterations PROGNOSTIC-SIGNIFICANCE THYROID-HORMONE SPLICE VARIANTS SURFACE EPITHELIUM HMG-BOX CAPILLARIES CHOP Motexafin gadolinium EMBRYONIC CARCINOMA-CELLS ANTICANCER AGENTS LARGE T-ANTIGEN GAMMA-CATENIN MECHANISM tissue ORAL-CANCER multipolar spindle STK15-interaction-RNAi-two-hybrid SUSCEPTIBILITY CYCLIC-NUCLEOTIDES GASTROINTESTINAL PERFORATION WEST-NILE-VIRUS STATISTICS SUPPRESSION PLASMA-LEVELS ANGIOGENESIS INHIBITOR precancer MDR MRP7-Cepharanthine-Paclitaxel-E(2)17 beta G transport Radiotherapy RECURRENT EPITHELIAL OVARIAN Hematology IN-VITRO DRUG-RESISTANCE COLORECTAL-CANCER mesothelioma OVARIAN TUMORIGENICITY CGH MULTICENTER NAD(P)H OXIDASE Neurologic progression CROHNS-DISEASE
Last updated on Wednesday, February 05, 2020